Australien - engelska - Department of Health (Therapeutic Goods Administration)

emcure pharmaceuticals pty ltd - pentamidine isetionate, quantity: 300 mg - injection, powder for - excipient ingredients: water for injections; nitrogen - pentamidine isethionate is indicated for intravenous administration in the treatment of the following conditions:,- as an alternative first line treatment for pneumocystis carinii infection in aids patients;,- as second line treatment for pneumocystis carinii infection in non-aids patients;,- as second line treatment of leishmaniasis (visceral and cutaneous), except leishmania aethiopica where it may be used as first line therapy;,- as second line treatment for trypanosomiasis (except for the trypanosomiasis rhodesiense strain due to lack of efficacy).

Australien - engelska - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - pentamidine isethionate -

Namibia - engelska - Namibia Medicines Regulatory Council

pharmaplan (pty) ltd - pentamidine isethionate - injection - pentamidine isethionate injection 500mg/vial

Kanada - engelska - Health Canada

david bull laboratories (pty) ltd. - pentamidine isetionate - powder for solution - 300mg - pentamidine isetionate 300mg - miscellaneous antiprotozoals

Kanada - engelska - Health Canada

marcan pharmaceuticals inc - pentamidine isetionate - powder for solution - 300mg - pentamidine isetionate 300mg - miscellaneous antiprotozoals

Kanada - engelska - Health Canada

pfizer canada ulc - pentamidine isetionate - powder for solution - 300mg - pentamidine isetionate 300mg - miscellaneous antiprotozoals

USA - engelska - NLM (National Library of Medicine)

fresenius kabi usa, llc - pentamidine isethionate (unii: v2p3k60da2) (pentamidine - unii:673lc5j4lq) - nebupent is indicated for the prevention of pneumocystis jiroveci pneumonia (pjp) in high-risk, hiv-infected patients defined by one or both of the following criteria: i. a history of one or more episodes of pjp ii. a peripheral cd4+ (t4 helper/inducer) lymphocyte count less than or equal to 200/mm3 . these indications are based on the results of an 18-month randomized, dose-response trial in high risk hiv-infected patients and on existing epidemiological data from natural history studies. the patient population of the controlled trial consisted of 408 patients, 237 of whom had a history of one or more episodes of pjp. the remaining patients without a history of pjp included 55 patients with kaposi’s sarcoma and 116 patients with other aids diagnoses, arc or asymptomatic hiv infection. patients were randomly assigned to receive nebupent via the respirgard® ii nebulizer at one of the following three doses: 30 mg every two weeks (n=135), 150 mg every two weeks (n=134) or 300 mg every four weeks (n=139). the

Australien - engelska - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - pentamidine isetionate, quantity: 300 mg - injection, powder for - excipient ingredients: - 1. as an alternative first line treatment for pneumocystis carinii infection in acquired immunodeficiency syndrome (aids) patients 2. as second line treatment for pneumocystis carinii infection in non-aids patients 3. as second line treatment of leishmaniasis (visceral and cutaneous), except leishmania aethiopica where it may be used as first line therapy 4. as second line treatment for trypanosomiasis (except for the trypanosomiasis rhodesiense strain).

Australien - engelska - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - pentamidine isetionate, quantity: 300 mg - injection, powder for - excipient ingredients: - 1. as an alternative first line treatment for pneumocystis carinii pneumonia/infection in aids patients. 2. as second line treatment for pneumocystis carinii pneumonia/infection in non-aids patients; 3. as second line treatment of leishmaniasis (visceral and cutaneous), except leishmania aethiopica where it may be used as first line therapy; 4. as second line treatment for trypanosomiasis (haemolymphete stage only) (except for the trypanosomiasis rhodesiense strain due to lack of efficacy).

Malta - engelska - Malta Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - pentamidine diisethionate - powder - pentamidine diisethionate 300 mg - antiprotozoals